NCT04159779Active, not recruiting
A Study of Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Greece
Clinical Outcomes of Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Routine Clinical Settings in Greece
Source: ClinicalTrials.gov · Last updated 17 Jul 2025
Brief summary (registry, in English)
This study is being done to evaluate the clinical outcomes of Chronic Lymphocytic Leukemia (CLL) participants treated with venetoclax as routine standard of care in Greece. The decision to treat with venetoclax is made by the participant's physician prior to being offered enrollment in this study. The objectives of this study include determining overall response rate, assessing safety information, analyzing patient profiles and disease characteristics and participant quality of life.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 180 (estimated)
- First submitted
- 8 Nov 2019
- Start date
- 13 Jan 2020
- Primary completion date
- 30 Jun 2026
- Lead sponsor
- AbbVie
- Diseases
- Chronic lymphocytic leukaemia
- NCT number
- NCT04159779
What you commit to
- Study type: Observational
- Planned participants: 180
- From 13 Jan 2020 to the primary completion date, 30 Jun 2026
- 21 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prescribed or treated with venetoclax outside of marketing authorization
- Currently participating in, or previously participated within 30 days prior to venetoclax start, in any other interventional clinical trial
Who the study is looking for
- Confirmed diagnosis of Chronic Lymphocytic Leukemia (CLL) according to the International Workshop on Chronic Lymphocytic Leukemia (iwCLL) criteria
- Eligible to receive venetoclax as per local label
- Physician has decided to initiate CLL treatment with venetoclax and the decision to treat is made by the physician in accordance with the local label prior to any decision to approach the participant about the study
- Participant has been fully informed verbally and in writing about the study and does not object to their data being processed or subjected to data quality control
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (21)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| General University Hospital of Alexandroupolis /ID# 212927 Coordinator of this site? Confirm its status | Alexandroupoli | Greece | Unknown status |
| Henry Dunnant Hospital Center /ID# 241682 Coordinator of this site? Confirm its status | Athens | Greece | Unknown status |
| General Hospital of Athens Gennimatas /ID# 212917 Coordinator of this site? Confirm its status | Athens | Greece | Unknown status |
| General Hospital of Athens Laiko /ID# 212902 Coordinator of this site? Confirm its status | Athens | Greece | Unknown status |
| General Hospital of Athens Laiko /ID# 230222 Coordinator of this site? Confirm its status | Athens | Greece | Unknown status |
| University General Hospital Attikon /ID# 212915 Coordinator of this site? Confirm its status | Athens | Greece | Unknown status |
| General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 212929 Coordinator of this site? Confirm its status | Athens | Greece | Unknown status |
| General Hospital of Chania "Agios Georgios" /ID# 241685 Coordinator of this site? Confirm its status | Chania | Greece | Unknown status |
| Metropolitan General /ID# 212934 Coordinator of this site? Confirm its status | Cholargós | Greece | Unknown status |
| University General Hospital of Heraklion PA.G.N.I /ID# 212916 Coordinator of this site? Confirm its status | Heraklion | Greece | Unknown status |
| University General Hospital of Ioannina /ID# 212936 Coordinator of this site? Confirm its status | Ioannina | Greece | Unknown status |
| Reg Gen Univ Hosp Larissa /ID# 213708 Coordinator of this site? Confirm its status | Larissa | Greece | Unknown status |
| Iatriko Kentro Athinon /ID# 241689 Coordinator of this site? Confirm its status | Marousi | Greece | Unknown status |
| Iatriko Kentro Athinon /ID# 241690 Coordinator of this site? Confirm its status | Marousi | Greece | Unknown status |
| General Hospital of Patras Agios Andreas /ID# 213711 Coordinator of this site? Confirm its status | Pátrai | Greece | Unknown status |
| University Gen Hosp of Patra /ID# 212914 Coordinator of this site? Confirm its status | Pátrai | Greece | Unknown status |
| METAXA Cancer Hospital of Piraeus /ID# 212918 Coordinator of this site? Confirm its status | Piraeus | Greece | Unknown status |
| Metropolitan Hospital /ID# 241687 Coordinator of this site? Confirm its status | Piraeus | Greece | Unknown status |
| Papageorgiou General Hospital /ID# 213710 Coordinator of this site? Confirm its status | Thessaloniki | Greece | Unknown status |
| General Hospital of Thessaloniki George Papanikolaou /ID# 213709 Coordinator of this site? Confirm its status | Thessaloniki | Greece | Unknown status |
| Theageneio Anticancer Hospital /ID# 212933 Coordinator of this site? Confirm its status | Thessaloniki | Greece | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.